The immunopharmacological characteristics of angelan, a polysaccharide
purified from Angelica gigas Nakai, were investigated in relation to
the specificity to immune cells. The treatment of angelan increased th
e expression of IL-2, IL-4, IL-6, and IFN-gamma. The expression of IL-
6 and IFN-gamma was rapidly augmented but that of IL-2 responded later
. In the case of IL-4, angelan stimulated at early time after exposure
but down-regulated thereafter. These results suggested that macrophag
es and natural killer cells involved in nonspecific immunity were prim
arily activated and helper T cells were secondarily affected by angela
n. Angelan also had lympho-proliferative potential to B cells, specifi
cally. The specificity of angelan was also elucidated in a cell fracti
onation experiment. The activated B cells by angelan also increased an
tibody production. The direct activation of B cells, macrophages, and
accessory cells and the indirect activation of helper T cells coordina
tely increased immune functions such as in vitro and in vivo T-depende
nt immunization and antibody production. The experiment of host resist
ance to syngeneic tumors also showed that angelan potentiated the immu
ne functions. In conclusion, angelan, a purified polysaccharide from a
n oriental herbal drug, showed characteristic immunostimulation, which
was different from clinically used polysaccharides such as lentinan a
nd PSK. (C) 1998 Elsevier Science B.V. All rights reserved.